Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

8.470 +0.430 (+5.35%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax Inc

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
60 61 Next >
US Study Shows Omicron As Severe As Previous COVID Variants: Reuters
Via Benzinga
Why Is Novavax Stock Rising This Week?
The quarterly results and FDA approval for EUA could push NVAX stock higher in the coming weeks, so take your position now. 
Via InvestorPlace
Novavax Whale Trades For May 03
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 45 strange trades. 
Via Benzinga
The Window of Opportunity Has Closed for Novavax
A series of missteps left Novavax far behind in the vaccine race. Continued delays and roadblocks continue to hurt NVAX stock. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Why Novavax Shares Are Rising
Shares of vaccine companies, including Novavax, Inc. (NASDAQ: NVAX), are trading higher amid COVID-19 concerns due to rising cases in China. 
Via Benzinga
Novavax Starts Dosing In COVID-19 Booster Trial In Participants Aged 12 - 17 Years
Via Benzinga
Novavax's COVID-19/Influenza Combo Vaccine Shows Immunogenicity In Early-Study
Via Benzinga
66 Biggest Movers From Yesterday
Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged... 
Via Benzinga
31 Stocks Moving In Monday's Mid-Day Session
Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) climbed 64.9% to $9.86. Redbox recently reported CFO transition. SoundHound AI, Inc. (NASDAQ: SOUN) shares gained 30.5% to $8.48... 
Via Benzinga
Fourth COVID-19 Shot? See Why Medical Professionals Are Skeptical
Medical professionals are undecided on whether a fourth dose of the Covid-19 vaccine would benefit the wider population, as countries are beginning to offer the fourth dose to vulnerable groups. 
Via Benzinga
Dear Novavax (NVAX) Stock Fans, Mark Your Calendars for June 7
NVAX stock is in the green after the FDA announced it would meet on June 7 to discuss the company's emergency use authorization request. 
Via InvestorPlace
FDA Sets Review Dates For Pfizer, Moderna COVID-19 Shot For Kids, Plus Novavax EUA
Via Benzinga
Nasdaq Eyes Worst Month Since 2008 as Stocks Resume Selloff
Wall Street is looking to close out the week with a loss after inflation data rolled in earlier today. 
Via Talk Markets
Novavax Surges As Its Covid Shot Approaches The FDA Finish Line
The FDA advisory committee will meet June 7 to discuss its Covid shot. 
Via Investor's Business Daily
This Is What Whales Are Betting On Novavax
A whale with a lot of money to spend has taken a noticeably bullish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 17 strange trades. 
Via Benzinga
Six US States Probing Mysterious Liver Inflammation In Kids: Bloomberg
At least six U.S. states are reporting confirmed or suspected cases of an unexplained, severe liver disorder in children. Health officials in New York state and Wisconsin said they’re investigating... 
Via Benzinga
Novavax Stock Is Now Speculative, But it Still Has a Shot
NVAX stock has become speculative, but it still has multiple ways to win. The company needs to step up its marketing game. 
Via InvestorPlace
Novavax Could Get Analyst Downgrades Leading Up to Earnings
Novavax recently got Nuvaxovid approved for use in Japan for both primary and booster shots. It’s done nothing for NVAX stock. 
Via InvestorPlace
7 Biggest Loser Stocks That Could Become Surprising Buys
A huge pouring of red ink can sometimes lead to extraordinary gains, though you’ve got to be aware of the risks. 
Via InvestorPlace
Biotechnology Stock Novavax Enters the Buying Area
Even though Novavax's engagement in vaccine development is of high public attention, the stock price is in a decline. Right now, we see the stock price entering an inflection area. Here, we present our... 
Via Talk Markets
The Daily Biotech Pulse: WHO Endorses Pfizer's Oral COVID Therapy, Vallon Pharma Surges On Strategic Review, Novavax Starts Dosing In Adolescents COVID Booster Trial
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Novavax Stock Could Give Back More of Its Pandemic-Era Gains
While trading at a very low multiple to the low end of earnings estimates, NVAX stock may still be trading at a premium. 
Via InvestorPlace
World's Largest Vaccine Manufacturer Stops Making COVID-19 Vaccines As 200M Doses Pile-Up: Bloomberg
Serum Institute of India Ltd, the world’s largest vaccine manufacturer, has stopped making new batches of COVID-19 shots after its stockpile grew to 200 million doses amid a global supply glut, 
Via Benzinga
Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ
Via Benzinga
Novavax Stock Looks Like a Good Value With Its New Combined Vaccine
NVAX stock could be worth 63% more based on its new combination flu and Covid-19 vaccine after passing Phase 1/2 clinical trials. 
Via InvestorPlace
Is Novavax a Buy After Its Vaccine Approval in Switzerland?
Novavax is late to the Covid-19 vaccine race and is up against some stiff competition. NVAX stock is in a tough spot. 
Via InvestorPlace
If You Invested $100 In Novavax 5 Years Ago, Here's How Much You Would Have Today
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 13.94% on an annualized basis producing an average annual return of 27.26%. Currently, Novavax has a market capitalization of... 
Via Benzinga
What's Going On With Novavax Stock Today?
Novavax Inc (NASDAQ: NVAX) shares are trading lower Tuesday. The stock fell to new 52-week lows early in the session, but has since recovered. Novavax on Tuesday... 
Via Benzinga
UK-Based Start-Up Working On Next COVID-19 Vaccine Using Animal Feces: FT
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
60 61 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.